Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Pharmatech"
Count: 17
Selected: 0
NCT IDTitle
NCT02749838Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens
NCT02749825Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
NCT00831597Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT00766246Phase II Avastin Trial for Stage IIIB/IV NSCLC
NCT01616303A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
NCT04608955Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
NCT050295183-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
NCT04296799A Phase 1 Study of SMP-100 in Normal Healthy Volunteers
NCT03730142A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma
NCT03934359A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors
NCT00027989Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
NCT00026442Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
NCT00026429Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
NCT00026351Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT03641794Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
NCT00496873Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
NCT00131313Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.